本页面由Tiger Trade Technology Pte. Ltd.提供服务

Syndax Pharmaceuticals, Inc.

16.91
+0.01000.06%
成交量:74.73万
成交额:1,268.21万
市值:15.10亿
市盈率:-6.74
高:17.42
开:16.91
低:16.78
收:16.90
52周最高:25.59
52周最低:12.99
股本:8,929.71万
流通股本:8,029.50万
量比:0.51
换手率:0.93%
股息:- -
股息率:- -
每股收益(TTM):-2.5100
每股收益(LYR):-3.2949
净资产收益率:-255.93%
总资产收益率:-18.67%
市净率:100.01
市盈率(LYR):-5.13

数据加载中...

2026/08/07

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/05

重要事件披露

Form 8-K - Current report
2026/07/14

重要事件披露

Form 8-K - Current report
2026/07/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/11

重要事件披露

Form 8-K - Current report
2026/06/11

重要事件披露

Form 8-K - Current report
2026/06/04

重要事件披露

Form 8-K - Current report
2026/06/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/30

重要事件披露

Form 8-K - Current report
2026/04/30

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/30

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/02/26

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/26

重要事件披露

Form 8-K - Current report
2026/02/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities